Hyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healing.

berberine chronic wounds hyaluronan nanogels ε-polylysine

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
28 Dec 2020
Historique:
received: 31 10 2020
revised: 15 12 2020
accepted: 22 12 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 1 1 2021
Statut: epublish

Résumé

Physiological wound healing process can be delayed in the presence of certain pathologies, such as diabetes or cancer. In this perspective, the aim of this study was to design a new nanogel platform of hyaluronan, poly-L-lysine and berberine suitable for wound treatment. Two different nanogel formulations were selected after a first formulation screening. They were prepared by adding dropwise 2 mg/mL hyaluronan aqueous solution (200 or 700 kDa) to 1.25 mg/mL poly-L-lysine aqueous solution. Blank nanogels formulated with 200 kDa HA resulted stable after freeze-drying with dimensions, polydispersity index and zeta potential of 263.6 ± 13.1 nm, 0.323 ± 0.029 and 32.7 ± 3.5 mV, respectively. Both blank and berberine-loaded nanogels showed rounded-shape structures. Loaded nanogels released nearly 50% of loaded berberine within 45 min, whereas the remaining 50% was released up to 24 h in vitro. Both, blank and berberine-loaded nanogels were able to completely close the fibroblasts gap in 42 h.

Identifiants

pubmed: 33379303
pii: pharmaceutics13010034
doi: 10.3390/pharmaceutics13010034
pmc: PMC7823568
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 2017 #20173ZECCM
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : SAF2017-83118-R
Organisme : Xunta de Galicia
ID : ED431C 2020/17
Organisme : Research Funding for University of Catania
ID : Piano per la Ricerca 2016-2018

Références

Chem Rec. 2010 Dec;10(6):366-76
pubmed: 20836092
ACS Appl Mater Interfaces. 2017 Nov 8;9(44):38908-38918
pubmed: 29035502
N Engl J Med. 1999 Sep 2;341(10):738-46
pubmed: 10471461
Int J Pharm. 2012 May 30;428(1-2):152-63
pubmed: 22388054
Nanoscale. 2019 Feb 7;11(6):2878-2891
pubmed: 30688341
J Antibiot (Tokyo). 1984 Nov;37(11):1449-55
pubmed: 6392269
PLoS Med. 2006 Dec;3(12):e493
pubmed: 17177600
Expert Opin Drug Deliv. 2017 Jul;14(7):897-908
pubmed: 27732106
Pharmacol Rep. 2015 Oct;67(5):970-9
pubmed: 26398393
Carbohydr Polym. 2017 Dec 1;177:194-202
pubmed: 28962758
J Biomater Appl. 2015 May;29(10):1418-27
pubmed: 25502767
Biomed Res Int. 2020 Mar 16;2020:3617514
pubmed: 32258115
Carbohydr Polym. 2018 Jun 1;189:379-398
pubmed: 29580422
J Biomater Sci Polym Ed. 2015;26(18):1343-56
pubmed: 26381379
Clin Nutr. 2012 Aug;31(4):469-75
pubmed: 22284340
ACS Appl Mater Interfaces. 2016 Jun 22;8(24):14958-65
pubmed: 26646202
ACS Nano. 2014 Aug 26;8(8):8374-82
pubmed: 25100313
Nanomedicine. 2019 Apr;17:391-400
pubmed: 30399437
Wound Repair Regen. 2012 May-Jun;20(3):317-31
pubmed: 22564227
Ann Med. 2002;34(6):419-27
pubmed: 12523497
J Control Release. 2016 Apr 28;228:159-169
pubmed: 26948381
Biochim Biophys Acta. 2008 Nov;1780(11):1348-61
pubmed: 18249195
Curr Opin Infect Dis. 2004 Apr;17(2):91-6
pubmed: 15021046
ACS Appl Mater Interfaces. 2020 Jun 24;12(25):27876-27888
pubmed: 32478498
Macromol Rapid Commun. 2014 Nov;35(21):1819-32
pubmed: 25283788
Mol Pharm. 2013 Aug 5;10(8):3076-89
pubmed: 23758289
Evid Based Complement Alternat Med. 2014;2014:289264
pubmed: 24669227
J Control Release. 2016 Oct 28;240:109-126
pubmed: 26571000
Bioresour Technol. 2006 Jun;97(9):1148-59
pubmed: 16551535
J Immunol. 2008 Aug 1;181(3):2103-10
pubmed: 18641349
Appl Microbiol Biotechnol. 2003 Jul;62(1):21-6
pubmed: 12728342
Int J Mol Sci. 2018 Apr 12;19(4):
pubmed: 29649179
Drug Deliv. 2005 Nov-Dec;12(6):327-42
pubmed: 16253949
Drug Deliv. 2017 Nov;24(1):539-557
pubmed: 28181831
Biochem Biophys Res Commun. 2013 Sep 13;439(1):148-53
pubmed: 23939043
J Dermatol Sci. 2013 Dec;72(3):206-17
pubmed: 23958517
Biochim Biophys Acta. 1999 Dec 15;1462(1-2):11-28
pubmed: 10590300
Colloids Surf B Biointerfaces. 2016 Oct 1;146:136-43
pubmed: 27288663
Adv Sci (Weinh). 2017 Jan 31;4(5):1600476
pubmed: 28546914
Curr Pharm Des. 2015;21(20):2801-13
pubmed: 25925117

Auteurs

Giovanni Amato (G)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Maria Aurora Grimaudo (MA)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.
Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Carmen Alvarez-Lorenzo (C)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Angel Concheiro (A)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Claudia Carbone (C)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Angela Bonaccorso (A)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Giovanni Puglisi (G)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Teresa Musumeci (T)

Department of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Classifications MeSH